PRLD
Prelude Therapeutics IncCompany with tickers: PRLD
Market Cap
$400.63M
Shares Outstanding
79,645,307
CIK
1678660
CUSIP
74065P101
13F Activity (30d)
2 filings
1 filers
Website
Visit website
Investor Relations
Investor relations
Press releases and events scraped from the company's investor relations website. News and event listings link back to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-06-10 | Goldman Sachs 47th Annual Global Healthcare Conference | Conference |
| 2026-06-03 | 2026 Jefferies Global Healthcare Conference | Conference |
| 2026-03-10 | Citizens Life Sciences Conference 2026 | Conference |
| 2025-11-12 | Prelude Therapeutics Third Quarter 2025 Financial Results Conference Call | Conference |
| 2025-06-11 | Goldman Sachs 46th Annual Global Healthcare Conference | Conference |
| 2025-06-05 | 2025 Jefferies Global Healthcare Conference | Conference |
| 2025-05-07 | Citizens Life Sciences Conference | Conference |
| 2025-03-11 | Barclays 27th Annual Global Healthcare Conference | Conference |
| 2024-12-02 | The Citizens JMP Hematology and Oncology Summit | Event |
| 2024-09-13 | PRT3789 Phase 1 Interim Clinical Data Update from 2024 ESMO Congress | Event |
Source: https://preludetx.com/investors/